About
Tianqiao Chen is the Founder, Chairman and Chief Executive Officer of Shanda Group. He is…
Articles by Tianqiao
-
My warmest congratulations for such an outstanding achievement .
My warmest congratulations for such an outstanding achievement .
“The idea of being able to precisely position and record from very specific areas, or even from specific neurons over…
2 Comments
Activity
-
I left xAI earlier this week and am joining MiroMind today. Over the past 8 months at xAI, I contributed to and led work on agentic tool use and…
I left xAI earlier this week and am joining MiroMind today. Over the past 8 months at xAI, I contributed to and led work on agentic tool use and…
Liked by Tianqiao Chen 陈天桥
-
Congratulations to Xiang Qian and QiLiang Chen, MD, PhD on their grant and research! Let's build a better mousetrap to treat TN!!
Congratulations to Xiang Qian and QiLiang Chen, MD, PhD on their grant and research! Let's build a better mousetrap to treat TN!!
Liked by Tianqiao Chen 陈天桥
-
Watching California’s latest tax bill debate, I keep coming back to one idea: for AI founders and investors, where you build is now as strategic as…
Watching California’s latest tax bill debate, I keep coming back to one idea: for AI founders and investors, where you build is now as strategic as…
Shared by Tianqiao Chen 陈天桥
Experience
-
-
-
-
-
Education
Honors & Awards
-
2018 Leadership Award for advancing U.S. – China Relations
Committee of 100
-
2017 Science Funder of the Year
INside Philanthropy
-
Forbes Asia 2017 "Hero of Philanthropy"
Forbes Asia
-
Top 25 "Stars of Asia"
Businessweek
-
Top 20 Global Outstanding Entrepreneurs under the age of 35 (2005)
Red Herring
-
TR100 Most Innovative List
MIT Technology Review
-
Robert Mundell World Executive Award
Haier Industries
More activity by Tianqiao
-
In Oregon, something changed. With updates to ORS 469.300, certain energy projects can now obtain land-use approval (CUP) in 6–12 months in places…
In Oregon, something changed. With updates to ORS 469.300, certain energy projects can now obtain land-use approval (CUP) in 6–12 months in places…
Shared by Tianqiao Chen 陈天桥
-
We Are Building the Infrastructure for a New Kind of AI – And We Need You At Miromind（MiroMind.ai), we are not trying to build “just another…
We Are Building the Infrastructure for a New Kind of AI – And We Need You At Miromind（MiroMind.ai), we are not trying to build “just another…
Shared by Tianqiao Chen 陈天桥
-
A few weeks ago we published our Memory Sparse Attention paper, a new way to give AI models long-term memory that actually works. Today's…
A few weeks ago we published our Memory Sparse Attention paper, a new way to give AI models long-term memory that actually works. Today's…
Liked by Tianqiao Chen 陈天桥
-
Gestala Founder & CEO Phoenix Peng joined the Bank of America Breakthrough Technology Dialogue APAC in Singapore. In an exclusive globally broadcast…
Gestala Founder & CEO Phoenix Peng joined the Bank of America Breakthrough Technology Dialogue APAC in Singapore. In an exclusive globally broadcast…
Liked by Tianqiao Chen 陈天桥
-
The Chen Institute is proud to present AIAS+ 2026 (AI Advancing Science & Society), where AI meets the frontiers of scientific discovery — taking…
The Chen Institute is proud to present AIAS+ 2026 (AI Advancing Science & Society), where AI meets the frontiers of scientific discovery — taking…
Liked by Tianqiao Chen 陈天桥
-
Thanks to all the guests, now we published all the winner projects on evermind.ai/activities
Thanks to all the guests, now we published all the winner projects on evermind.ai/activities
Liked by Tianqiao Chen 陈天桥
-
Welcome Professor Trevor Robbins to the Scientific Advisory Board (SAB) of Gestala! 🎉 Professor Robbins was the first Professor of Cognitive…
Welcome Professor Trevor Robbins to the Scientific Advisory Board (SAB) of Gestala! 🎉 Professor Robbins was the first Professor of Cognitive…
Liked by Tianqiao Chen 陈天桥
-
I am looking to hire someone for corp / biz dev and IR. Ideally based in Bay Area to be in our San Jose office but can try to be flexible for the…
I am looking to hire someone for corp / biz dev and IR. Ideally based in Bay Area to be in our San Jose office but can try to be flexible for the…
Liked by Tianqiao Chen 陈天桥
Other similar profiles
Explore more posts
-
Vinay Mehta
A new centre in San Francisco will offer #tailormade #CRISPR therapies to cure #children with #rarediseases. The centre will be led by Fyodor Urnov from Berkeley’s Innovative Genomics Institute, who co-developed the #CRISPR therapy for baby KJ and will collaborate closely with Danaher Corporation subsidiaries to manufacture clinical-grade CRISPR treatments at speed, and clinical treatment will take place at the University of California, San Francisco. Chan Zuckerberg Initiative is the sponsor of this Centre. https://lnkd.in/gsyHapW5 Vijay Chandru. Shridhar Narayanan
-
Cher Siong Quan
On September 10, 2025, quantum computing startup PsiQuantum announced it raised $1 billion in a Series E funding round, valuing the company at $7 billion. This funding will be used to advance its quantum computer development, including establishing new sites in Brisbane, Australia, and Chicago, Illinois, as well as deploying large-scale test systems. 💰 Key Investors and Partners The funding round was led by major investment firms: BlackRock Temasek Baillie Gifford New investors also participated, including: NVentures, the venture capital arm of Nvidia Macquarie Capital Ribbit Capital Adage Capital Management Qatar Investment Authority Type One Ventures Existing investors, such as Blackbird and Third Point Ventures, also contributed. Collaboration with Nvidia. 🤝 In addition to its investment, Nvidia has partnered with PsiQuantum. The collaboration will focus on several key development areas: Quantum algorithms and software: Creating the programming to run on quantum computers. GPU-QPU integration: Connecting Nvidia's graphics processing units (GPUs) with PsiQuantum's quantum processing units (QPUs). Silicon photonics platform: Advancing PsiQuantum's core technology, which uses photons as qubits and leverages standard semiconductor manufacturing. This partnership underscores Nvidia's growing interest in quantum computing, building on its existing efforts in quantum simulation software and research. Source: The Business Times https://search.app/kzbna
-
AMPulse Online
🚀 Startup Spotlight 🚀 Huaqing Zhimei - A high-tech biotechnology firm specializing in the industrialization of Bio-3D printing and human-engineered extracellular matrix (hEECM) materials for regenerative medicine and medical aesthetics. 🔍 Company Overview - CEO: Liu Boxun - Year Founded: 2021 - Location: Shenzhen, China - Team Size: 51-100 - Webpage: https://www.hmcell.com 🎯 What They Do - One-line Description: A high-tech biotechnology firm specializing in the industrialization of Bio-3D printing and human-engineered extracellular matrix (hEECM) materials for regenerative medicine and medical aesthetics. - Target Customers: Medical aesthetics clinics, dermatology hospitals, plastic surgery centers, and pharmaceutical research institutions. - Industry Verticals: Materials 🚀 Achievements & Status - Current Stage/Status: Post-Series A commercialization; operating a 2,000sqm GMP-standard production facility in Shenzhen with established product lines in the medical aesthetics market. - Major Milestones: Series A - Key Investors: Established the first national industry standard for ECM in China (2023),Successful launch of the 'Meibiyuan' (美泌源) high-end regenerative aesthetics brand,Completion of a 2,000sqm GMP bioactive material production line in Shenzhen (2024),Series A funding round of tens of millions of CNY (June 2024) - Basic Growth Metrics: Operating a 2,000-square-meter GMP-standard production facility in Shenzhen; established the first national industry standard for Extracellular Matrix (ECM) in China. 💡 Competitive Edge - How They Differentiate: Huaqing Zhimei differentiates through its 'Super Cell Factory' model. Unlike competitors who focus on recombinant single-protein collagen (expressed in yeast/E.coli), Huaqing Zhimei uses proprietary Bio-3D printing to create structured environments where human cells secrete a complete 'Human Engineered Extracellular Matrix' (hEECM) containing over 1,000 types of active proteins, achieving 100% bio-homology. - Key Technological Advantage: Pioneered the transition from 'printing organs' (long-term research) to 'printing factories' (immediate commercialization), solving the scalability and cost issues of high-purity human-derived bioactive materials. 📈 Funding & Partnerships - Total Funding Raised: $6.2M - Latest Funding Round: Series A - Key Investors: Leaguer Capital (力合创投),Shaanxi Financial Holding (陕西金控),Zijing Hongxin (紫荆泓鑫) - Key Partnerships/Collaborations: Research Institute of Tsinghua University in Shenzhen (Founding incubator),Shenzhen Young Science and Technology Association,Leaguer Capital (Investment & strategic ecosystem partner),Various Top-tier Class-A hospitals in China for clinical research Based on database updated on: 2026-01-14T15:37:45.074+09:00 #Innovation #AM #3Dprinting Powered by #WeeklyVentures "Spot an error? Share your feedback to help us improve!" https://lnkd.in/dhJVjbyH
-
Francesca Hallworth
Proxima has raised an $80 million oversubscribed seed round led by DCVC, with participation from NVIDIA NVentures and other leading investors. Formerly VantAI, the company has rebranded as Proxima to reflect its focus on building the data and AI infrastructure needed to enable the next generation of proximity based medicines, including molecular glues and targeted protein degradation. A seed round of this scale clearly demonstrates growing investor confidence in AI native drug discovery and the potential of proximity based medicines. #biotech #ai #funding #seed
1 Comment
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content